Johns Hopkins HIV Guide
Rifabutin
INDICATIONS
FDA
FDA
- Prophylaxis of Mycobacterium avium complex (MAC) in patients with AIDS.
- Treatment of H. pylori infections in combination with other agents.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of disseminated MAC in patients with AIDS (in combination with a macrolide plus ethambutol).
- Treatment of TB in patients with AIDS who are taking PIs or NNRTIs.
- Treatment of latent TB in patients intolerant to INH. Rifabutin x 4 months can be considered.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: July 4, 2021
Citation
Avdic, Edina. "Rifabutin." Johns Hopkins HIV Guide, 2021. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545182/all/Rifabutin.
Avdic E. Rifabutin. Johns Hopkins HIV Guide. 2021. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545182/all/Rifabutin. Accessed September 28, 2023.
Avdic, E. (2021). Rifabutin. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545182/all/Rifabutin
Avdic E. Rifabutin [Internet]. In: Johns Hopkins HIV Guide. ; 2021. [cited 2023 September 28]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545182/all/Rifabutin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rifabutin
ID - 545182
A1 - Avdic,Edina,Pharm.D.
Y1 - 2021/07/04/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545182/all/Rifabutin
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
